BioSyent, Inc. (RX.V)
15.73
-0.33
(-2.05%)
CAD |
TSXV |
Sep 18, 16:00
BioSyent Market Cap : 178.38M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 178.38M |
| September 17, 2026 | 182.13M |
| September 16, 2026 | 182.35M |
| September 15, 2026 | 181.22M |
| September 14, 2026 | 179.74M |
| September 11, 2026 | 177.59M |
| September 10, 2026 | 177.48M |
| September 09, 2026 | 177.93M |
| September 08, 2026 | 179.74M |
| September 04, 2026 | 181.10M |
| September 03, 2026 | 180.08M |
| September 02, 2026 | 181.44M |
| September 01, 2026 | 179.97M |
| August 31, 2026 | 181.33M |
| August 28, 2026 | 178.61M |
| August 27, 2026 | 180.88M |
| August 26, 2026 | 179.63M |
| August 25, 2026 | 178.04M |
| August 24, 2026 | 175.77M |
| August 21, 2026 | 178.04M |
| August 20, 2026 | 167.27M |
| August 19, 2026 | 167.27M |
| August 18, 2026 | 165.57M |
| August 17, 2026 | 165.57M |
| August 14, 2026 | 172.94M |
| Date | Value |
|---|---|
| August 13, 2026 | 170.22M |
| August 12, 2026 | 167.84M |
| August 11, 2026 | 170.10M |
| August 10, 2026 | 170.10M |
| August 07, 2026 | 170.10M |
| August 06, 2026 | 175.66M |
| August 05, 2026 | 175.77M |
| August 04, 2026 | 166.14M |
| July 31, 2026 | 167.27M |
| July 30, 2026 | 166.25M |
| July 29, 2026 | 166.25M |
| July 28, 2026 | 167.27M |
| July 27, 2026 | 167.16M |
| July 24, 2026 | 167.16M |
| July 23, 2026 | 166.59M |
| July 21, 2026 | 166.70M |
| July 20, 2026 | 164.43M |
| July 17, 2026 | 164.43M |
| July 16, 2026 | 164.43M |
| July 15, 2026 | 165.57M |
| July 14, 2026 | 165.57M |
| July 13, 2026 | 165.46M |
| July 10, 2026 | 165.57M |
| July 09, 2026 | 166.93M |
| July 08, 2026 | 166.02M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| HLS Therapeutics, Inc. | 122.26M |
| Bausch Health Cos., Inc. | 2.961B |
| Cipher Pharmaceuticals, Inc. | 372.84M |
| Revive Therapeutics Ltd. | 8.714M |
| Knight Therapeutics, Inc. | 1.007B |
Market Cap Related Metrics
| PE Ratio | 18.35 |
| PS Ratio | 3.249 |
| PEG Ratio | 0.925 |
| Price to Book Value | 3.891 |
| Price to Free Cash Flow | 15.55 |
| Price | 15.73 |
| Earnings Yield | 5.45% |
| PEGY Ratio | 0.8654 |
| Operating PE Ratio | 14.02 |
| Normalized PE Ratio | 18.35 |